Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 28 January, 2010 and appeared in  Issue 506Type 2 DiabetesSpecial Edition - Best of 2010

Test Your Knowledge #506: A 58-year-old woman who has had Type 2 diabetes for 15 years is evaluated at a routine...

A 58-year-old woman who has had Type 2 diabetes for 15 years is evaluated at a routine follow-up examination. She has coexisting hypertension, hyperlipidemia, and background retinopathy but no other known microvascular or macrovascular complications of diabetes. Medications include glimepiride 8 mg/day, metformin 1000 mg twice daily, lisinopril 20 mg/day, hydrochlorothiazide 12.5 mg/day, atorvastatin 20 mg/day, and low-dosage aspirin. She adheres to a meal plan and walks for 30 minutes daily 5 days per week. Her body mass index is 29. Background retinopathy is confirmed. Her hemoglobin A1c value is 8.5% and fasting glucose level is 185 mg/dL (10.27 mmol/L).

Advertisement

Which of the following therapeutic options is most appropriate for this patient?

A. Start exenatide.
B. Start glargine at bedtime.
C. Start 70/30 premixed insulin at breakfast.
D. Stop metformin and start pioglitazone.

For the correct answer, please click here.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 28 January, 2010 and appeared in  Issue 506Type 2 DiabetesSpecial Edition - Best of 2010

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

2012 Most Popular Articles:

ADA/EASD Issue New Hyperglycemia Management Guidelines
Posted April 26, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
It’s the Variety of Fruit-and-Veggie That Lower Diabetes Risk
Posted May 03, 2012
Ultra-Long-Acting Insulin Degludec, Two New Studies
Posted April 26, 2012
Eating Low Glycemic Index Foods at Breakfast Can Control Blood Sugar throughout the Day
Posted April 18, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Metformin May Not Be the Golden Pill After All for Treating Type 2 Diabetes
Posted April 18, 2012
Doubts Over Long Term Effectiveness of Group Education for Diabetes Patients
Posted May 03, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control